1. Home
  2. MATW vs ABUS Comparison

MATW vs ABUS Comparison

Compare MATW & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Matthews International Corporation

MATW

Matthews International Corporation

HOLD

Current Price

$26.58

Market Cap

827.2M

ML Signal

HOLD

Logo Arbutus Biopharma Corporation

ABUS

Arbutus Biopharma Corporation

HOLD

Current Price

$4.08

Market Cap

888.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MATW
ABUS
Founded
1850
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
827.2M
888.5M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
MATW
ABUS
Price
$26.58
$4.08
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
223.2K
1.6M
Earning Date
02-03-2026
11-13-2025
Dividend Yield
3.83%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,497,689,000.00
$14,606,000.00
Revenue This Year
N/A
$125.30
Revenue Next Year
$0.77
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
116.64
52 Week Low
$18.50
$2.71
52 Week High
$30.96
$5.10

Technical Indicators

Market Signals
Indicator
MATW
ABUS
Relative Strength Index (RSI) 46.83 37.37
Support Level $26.23 $3.99
Resistance Level $28.86 $4.33
Average True Range (ATR) 1.08 0.23
MACD -0.21 -0.07
Stochastic Oscillator 9.02 29.66

Price Performance

Historical Comparison
MATW
ABUS

About MATW Matthews International Corporation

Matthews International Corp is a provider of memorialization products, industrial technologies and brand solutions. The company's segments are Memorialization, Industrial Technologies and Brand Solutions. The memorialization offerings include bronze and granite memorials, caskets, and cremation-related products and equipment for cemeteries and funeral homes. Its Industrial Technologies segment designs, manufactures, services, and sells custom energy storage systems and product identification and warehouse automation solutions. The Brand Solutions segment provides brand management, pre-media, printing plates and cylinders, imaging, digital asset management, merchandising displays, and marketing and design services. The majority of revenue is generated by Memorialization.

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

Share on Social Networks: